查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886297

長效藥物遞送技術及服務市場－全球產業規模、佔有率、趨勢、機會及預測，依技術、劑型、所用材料、通路、地區及競爭格局分類，2020-2030年預測

Long-Acting Drug Delivery Technologies and Services Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By Dosage Forms, By Material Used, By Distribution Channels, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球長效藥物遞送技術與服務市場規模為107.8億美元，預計2030年將以11.10%的複合年成長率成長至202.7億美元。長效藥物遞送技術和服務涵蓋旨在延長藥物釋放時間的系統，從而減少給藥頻率並提高患者依從性。推動市場擴張的主要因素包括：慢性疾病盛行率的不斷上升，使得患者需要持續用藥才能達到最佳治療效果；以及患者對更便捷用藥方式（尤其是注射或植入劑）的需求日益成長。此外，維持穩定的藥物濃度，從而最大限度地減少峰谷效應，也是推動這些創新遞送解決方案發展的重要因素。

市場概覽
預測期 2026-2030
市場規模：2024年 107.8億美元
市場規模：2030年 202.7億美元
複合年成長率：2025-2030年 11.10%
成長最快的細分市場 注射劑
最大的市場 北美洲

主要市場促進因素

全球慢性病負擔日益加重，顯著影響了對長效藥物傳遞技術和服務的需求，因為這些疾病需要長期持續的治療管理。糖尿病、心血管疾病和各種神經系統疾病等都需要維持穩定的藥物濃度，以預防併發症並改善患者預後。

主要市場挑戰

新型長效製劑研發所需的大量資金投入，對全球長效藥物遞送技術和服務市場的成長構成了顯著阻礙。這項挑戰直接導致創新產品上市前需要投入大量資金，並延長研發週期。

主要市場趨勢

生物製劑長效製劑日益受到重視，這代表了藥物遞送市場的一大趨勢，其驅動力在於治療分子的複雜性不斷增加。這些製劑能夠延長生物製劑的半衰期，從而減少注射次數，這對於提高患者的舒適度和依從性至關重要，尤其對於慢性病患者而言。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球長效藥物遞送技術與服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術分類（注射劑、水凝膠、植入物、微針、奈米晶體懸浮液）
    • 依劑型分類（長效注射劑、長效植入劑、外用/透皮製劑、陰道製劑、其他）
    • 依所用材料分類（聚合物基、非聚合物基）
    • 按分銷管道（醫院和零售藥局、研究和學術機構、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美長效藥物遞送技術與服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲長效藥物遞送技術與服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區長效藥物遞送技術及服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東及非洲長效藥物遞送技術及服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲長效藥物遞送技術與服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球長效藥物遞送技術與服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Adare Pharma Solutions
  • Alkermes plc
  • Camurus AB
  • Corium, LLC.
  • Creative Biolabs, Inc.
  • Delpor, Inc.
  • Durect Corporation
  • Hanmi Pharm.Co.,Ltd.
  • Integrated Bio Systems, Inc.
  • Heron Therapeutics, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23925

The Global Long-Acting Drug Delivery Technologies and Services Market, valued at USD 10.78 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 20.27 Billion by 2030. Long-acting drug delivery technologies and services encompass systems designed to release therapeutic agents over extended periods, reducing dosing frequency and improving patient adherence. Primary drivers supporting market expansion include the increasing prevalence of chronic diseases necessitating sustained medication for optimal management and the growing demand for enhanced patient convenience, especially for injectable or implantable formulations. The inherent benefit of maintaining consistent drug levels, thereby minimizing peak-and-trough effects, also represents a fundamental driver for these innovative delivery solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 10.78 Billion
Market Size 2030USD 20.27 Billion
CAGR 2025-203011.10%
Fastest Growing SegmentInjectables
Largest MarketNorth America

Key Market Drivers

The rising global burden of chronic diseases significantly influences the demand for long-acting drug delivery technologies and services, as these conditions necessitate sustained therapeutic management over extended periods. Diseases such as diabetes, cardiovascular disease, and various neurological disorders require consistent medication levels to prevent complications and improve patient outcomes.

Key Market Challenges

The significant financial investment associated with research and development (R&D) for novel long-acting formulations presents a notable impediment to the growth of the Global Long-Acting Drug Delivery Technologies and Services Market. This challenge directly results in substantial capital requirements and prolonged timelines before innovative products can achieve market entry. The complexity of developing formulations that ensure sustained release and stability over extended periods necessitates extensive preclinical and clinical testing, further escalating costs and extending development cycles.

Key Market Trends

The growing emphasis on biologic-based long-acting formulations represents a significant trend in the drug delivery market, driven by the increasing complexity of therapeutic molecules. These formulations extend the half-life of biologics, thereby reducing the frequency of injections which is crucial for patient comfort and adherence, especially for chronic conditions. Biologics, including monoclonal antibodies and protein-based therapies, often require complex manufacturing and administration regimens, making long-acting versions highly advantageous.

Key Market Players

  • Adare Pharma Solutions
  • Alkermes plc
  • Camurus AB
  • Corium, LLC.
  • Creative Biolabs, Inc.
  • Delpor, Inc.
  • Durect Corporation
  • Hanmi Pharm.Co.,Ltd.
  • Integrated Bio Systems, Inc.
  • Heron Therapeutics, Inc.

Report Scope:

In this report, the Global Long-Acting Drug Delivery Technologies and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long-Acting Drug Delivery Technologies and Services Market, By Technique:

  • Injectables
  • Hydrogels
  • Implants
  • Microneedles
  • NanocrystalSuspensions

Long-Acting Drug Delivery Technologies and Services Market, By Dosage Forms:

  • Long-acting Injectables
  • Long-acting Implantable
  • Topical / Transdermal
  • Vaginal
  • Other

Long-Acting Drug Delivery Technologies and Services Market, By Material Used:

  • Polymer based
  • Non-polymer based

Long-Acting Drug Delivery Technologies and Services Market, By Distribution Channels:

  • Hospitals and Retail Pharmacies
  • Research and Academics
  • Others

Long-Acting Drug Delivery Technologies and Services Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Long-Acting Drug Delivery Technologies and Services Market.

Available Customizations:

Global Long-Acting Drug Delivery Technologies and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Injectables, Hydrogels, Implants, Microneedles, NanocrystalSuspensions)
    • 5.2.2. By Dosage Forms (Long-acting Injectables, Long-acting Implantable, Topical / Transdermal, Vaginal, Other)
    • 5.2.3. By Material Used (Polymer based, Non-polymer based)
    • 5.2.4. By Distribution Channels (Hospitals and Retail Pharmacies, Research and Academics, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Dosage Forms
    • 6.2.3. By Material Used
    • 6.2.4. By Distribution Channels
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Dosage Forms
        • 6.3.1.2.3. By Material Used
        • 6.3.1.2.4. By Distribution Channels
    • 6.3.2. Canada Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Dosage Forms
        • 6.3.2.2.3. By Material Used
        • 6.3.2.2.4. By Distribution Channels
    • 6.3.3. Mexico Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Dosage Forms
        • 6.3.3.2.3. By Material Used
        • 6.3.3.2.4. By Distribution Channels

7. Europe Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Dosage Forms
    • 7.2.3. By Material Used
    • 7.2.4. By Distribution Channels
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Dosage Forms
        • 7.3.1.2.3. By Material Used
        • 7.3.1.2.4. By Distribution Channels
    • 7.3.2. France Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Dosage Forms
        • 7.3.2.2.3. By Material Used
        • 7.3.2.2.4. By Distribution Channels
    • 7.3.3. United Kingdom Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Dosage Forms
        • 7.3.3.2.3. By Material Used
        • 7.3.3.2.4. By Distribution Channels
    • 7.3.4. Italy Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Dosage Forms
        • 7.3.4.2.3. By Material Used
        • 7.3.4.2.4. By Distribution Channels
    • 7.3.5. Spain Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Dosage Forms
        • 7.3.5.2.3. By Material Used
        • 7.3.5.2.4. By Distribution Channels

8. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Dosage Forms
    • 8.2.3. By Material Used
    • 8.2.4. By Distribution Channels
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Dosage Forms
        • 8.3.1.2.3. By Material Used
        • 8.3.1.2.4. By Distribution Channels
    • 8.3.2. India Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Dosage Forms
        • 8.3.2.2.3. By Material Used
        • 8.3.2.2.4. By Distribution Channels
    • 8.3.3. Japan Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Dosage Forms
        • 8.3.3.2.3. By Material Used
        • 8.3.3.2.4. By Distribution Channels
    • 8.3.4. South Korea Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Dosage Forms
        • 8.3.4.2.3. By Material Used
        • 8.3.4.2.4. By Distribution Channels
    • 8.3.5. Australia Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Dosage Forms
        • 8.3.5.2.3. By Material Used
        • 8.3.5.2.4. By Distribution Channels

9. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Dosage Forms
    • 9.2.3. By Material Used
    • 9.2.4. By Distribution Channels
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Dosage Forms
        • 9.3.1.2.3. By Material Used
        • 9.3.1.2.4. By Distribution Channels
    • 9.3.2. UAE Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Dosage Forms
        • 9.3.2.2.3. By Material Used
        • 9.3.2.2.4. By Distribution Channels
    • 9.3.3. South Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Dosage Forms
        • 9.3.3.2.3. By Material Used
        • 9.3.3.2.4. By Distribution Channels

10. South America Long-Acting Drug Delivery Technologies and Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Dosage Forms
    • 10.2.3. By Material Used
    • 10.2.4. By Distribution Channels
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Dosage Forms
        • 10.3.1.2.3. By Material Used
        • 10.3.1.2.4. By Distribution Channels
    • 10.3.2. Colombia Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Dosage Forms
        • 10.3.2.2.3. By Material Used
        • 10.3.2.2.4. By Distribution Channels
    • 10.3.3. Argentina Long-Acting Drug Delivery Technologies and Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Dosage Forms
        • 10.3.3.2.3. By Material Used
        • 10.3.3.2.4. By Distribution Channels

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Long-Acting Drug Delivery Technologies and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Adare Pharma Solutions
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Alkermes plc
  • 15.3. Camurus AB
  • 15.4. Corium, LLC.
  • 15.5. Creative Biolabs, Inc.
  • 15.6. Delpor, Inc.
  • 15.7. Durect Corporation
  • 15.8. Hanmi Pharm.Co.,Ltd.
  • 15.9. Integrated Bio Systems, Inc.
  • 15.10. Heron Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer